Carregant...
Moving treatments earlier to move further forward
In 2017, results from phase III trials demonstrated the impressive safety and efficacy of adjuvant targeted and immune therapies in patients with resectable stage III–IV melanoma, and raised questions about the surgical management of patients with microscopic sentinel-lymph-node metastases. For pati...
Guardat en:
| Publicat a: | Nat Rev Clin Oncol |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7436336/ https://ncbi.nlm.nih.gov/pubmed/29182162 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrclinonc.2017.183 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|